CC BY-NC-ND 4.0 · Journal of Fetal Medicine 2017; 04(04): 199-202
DOI: 10.1007/s40556-017-0138-y
Brief Communication

Prenatal Diagnosis of a 20 Mb Terminal Fetal 4q-Deletion in the Cytoband q33q35.2 Inherited from the Mother

K. V. Seneesh
1   Feto-Maternal Medicine, Centre for Infertility and Assisted Reproduction (CIMAR), Edappal Hospitals Private Limited, Edappal, Kerala, India
2   Lakshmi Bhavan, Pallipuram P.O, Via Pattambi, 679305, Palakkad, Kerala, India
,
Vipin Chandra
1   Feto-Maternal Medicine, Centre for Infertility and Assisted Reproduction (CIMAR), Edappal Hospitals Private Limited, Edappal, Kerala, India
,
Bijoy Balakrishnan
1   Feto-Maternal Medicine, Centre for Infertility and Assisted Reproduction (CIMAR), Edappal Hospitals Private Limited, Edappal, Kerala, India
,
Meenu Batra
1   Feto-Maternal Medicine, Centre for Infertility and Assisted Reproduction (CIMAR), Edappal Hospitals Private Limited, Edappal, Kerala, India
,
R. Sreeja
1   Feto-Maternal Medicine, Centre for Infertility and Assisted Reproduction (CIMAR), Edappal Hospitals Private Limited, Edappal, Kerala, India
,
Swapneel Patil
1   Feto-Maternal Medicine, Centre for Infertility and Assisted Reproduction (CIMAR), Edappal Hospitals Private Limited, Edappal, Kerala, India
,
Gopinathan Kannoly
1   Feto-Maternal Medicine, Centre for Infertility and Assisted Reproduction (CIMAR), Edappal Hospitals Private Limited, Edappal, Kerala, India
› Institutsangaben

Abstract

The authors present a case of prenatally diagnosed fetal terminal 4q deletion in the cytoband 4q33q35.2, inherited from the mother. The index pregnancy was referred at 28+2 weeks of gestation for polyhdramnios. Prior to performing the scan, distinctive facial features were noted in the mother. Target scan confirmed polyhdramnios, and revealed fetal retrognathia. The fetal karyotype reported a terminal 4q33>ter deletion, which was further delineated by chromosomal microarray analysis. Subsequently, maternal karyotype revealed identical deletion. Subtle fetal ultrasound abnormalities should receive meticulous assessment, and evaluation using the currently available wide range of cytogenetic and molecular gene tests.



Publikationsverlauf

Eingereicht: 08. Februar 2017

Angenommen: 23. August 2017

Artikel online veröffentlicht:
08. Mai 2023

© 2017. Society of Fetal Medicine. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India